Condition: Dry Eye Disease (DED) · Sponsor: Dompé Farmaceutici S.p.A
This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical ophthalmic solution versus vehicle in participants with dry eye disease. Approximately 417 participants aged 18 years or older who meet all eligibility criteria will be enrolled at study sites in the US. The study duration will be up to 16 weeks and will consist of three periods.
This description comes directly from the study's public registry record.
Dompé farmaceutici S.p.A. Via Santa Lucia, 6, 20122 Milan (MI) · +39 02 583 831
Always discuss trial participation with your own doctor first.
| Arizona Eye Center | Chandler, Arizona, United States | Recruiting |
| Canyon City Eyecare | Azusa, California, United States | Recruiting |
| Global Research Management, Inc. | Glendale, California, United States | Recruiting |
| United Medical Research Institute | Inglewood, California, United States | Recruiting |
| LoBue Laser and Eye Medical Center | Murrieta, California, United States | Not Yet Recruiting |
| Eye Research Foundation | Newport Beach, California, United States | Recruiting |
| NVision Clinical Research, LLC | Torrance, California, United States | Recruiting |
| Shettle Eye Research, Inc. | Largo, Florida, United States | Not Yet Recruiting |
| University of South Florida - Marshall Student Center | Tampa, Florida, United States | Not Yet Recruiting |
| Clayton Eye Clinical Research | Morrow, Georgia, United States | Recruiting |
| Price Vision Group / Cornea Research Foundation of America | Indianapolis, Indiana, United States | Recruiting |
| Minnesota Eye Consultants | Minnetonka, Minnesota, United States | Not Yet Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07503886